SEC Form 4 · accession 0001225208-16-028097
WEST PHARMACEUTICAL SERVICES INC · WST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Karen Flynn
Officer — President, Pharma Pckg Systems
Period of report
Feb 23, 2016
Accepted (ET)
Feb 25, 2016 · 11:17 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 23, 2016 | A | 3,914 | $59.64 | A | 27,966 | D | |
| Common Stock | holding | — | — | — | 312 | I | By Savings Plan | |
| Common Stock | holding | — | — | — | 1,127 | I | Non-Qualified Deferred Compensation Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $59.64 | Feb 23, 2016 | A | 26,020 | A | Feb 23, 2017 | Feb 23, 2026 | Common Stock | 26,020 | 26,020 | D |
Explanation of responses
- F1Shares represent the portion of the Performance Share Unit Award granted in 2013 that have vested for period 12.
- F2Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.